OTTINI, ARIANNA
OTTINI, ARIANNA
Universita' degli Studi di MILANO
Claudin-1 in Head and Neck Squamous Cell Carcinoma
2024 S. Cavalieri, C. Bergamini, D. Lenoci, A. Ottini, M. Lucchetta, E. Torchia, L. Licitra, L. De Cecco
Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature
2023 L. Giannini, A. Alliata, V. Cristofaro, F. Incandela, M. Pompilio, A. Ottini, S. Cavalieri, I. Nuzzolese, N.A. Iacovelli, M. Franceschini, A. Deganello
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
2023 S. Cavalieri, F. Platini, F. Barretta, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, N.A. Iacovelli, M. Franceschini, G. Calareso, P. Di Pede, G. De Feo, M. Gandelli, L. Toffolatti, M. Guglielmo, C.I. Ripamonti, L. Cosmai, L. Licitra, S. Alfieri
NUT carcinoma of the submandibular gland: A case report
2023 S. Rota, P. Quattrone, G. Centonze, G. Dagrada, A. Ottini, E. Colombo, I. Nuzzolese, G. Calareso, M. Franceschini, N.A. Iacovelli, F. Perrone, E. Tamborini, S. Cavalieri
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
2023 S. Cavalieri, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, S. Alfieri, P. Quattrone, G. Calareso, N.A. Iacovelli, M. Franceschini, L. Licitra
Management of patients with skin adnexal carcinomas
2023 S. Cavalieri, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, E. Colombo, A. Ottini, L. Licitra
Biomarker-driven immunotherapy for precision medicine in prostate cancer
2022 A. Ottini, P. Sepe, T. Beninato, M. Claps, V. Guadalupi, E. Verzoni, P. Giannatempo, G. Baciarello, F. De Braud, G. Procopio
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
2022 A. Mennitto, E. Zattarin, M. Di Maio, D. Bimbatti, U. De Giorgi, S. Buti, D. Santini, C. Casadei, M. Soraru, C. Messina, C. Mucciarini, G. Di Lorenzo, G. Roviello, C. Buttigliero, M. Stellato, P. Sepe, M. Claps, V. Guadalupi, A. Ottini, S. Pignata, F.G. De Braud, E. Verzoni, G. Procopio
Management of serious complications in intra-abdominal desmoid-type fibromatosis
2021 F. Bini, M. Fiore, S. Provenzano, R. Bertulli, A. Ottini, C. Colombo, M. Vitellaro, G. Greco, C. Morosi, A. Gronchi, P.G. Casali, E. Palassini
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients
2021 F. Ligorio, L. Zambelli, A. Bottiglieri, L. Castagnoli, E. Zattarin, R. Lobefaro, A. Ottini, A. Vingiani, S.M. Pupa, G.V. Bianchi, G. Capri, G. Pruneri, F. de Braud, C. Vernieri
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
2021 S. Cavalieri, D.M. Filippini, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, R. Lombardo, I. Nuzzolese, S. Alfieri, L. Licitra, L.D. Locati
Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers
2018 R.M. Trimboli, M. Codari, K. Khouri Chalouhi, I. Ioan, G. Lo Bue, A. Ottini, D. Casolino, L.A. Carbonaro, F. Sardanelli